FMA
AMAG

FNY Managed Accounts’s AMAG Pharmaceuticals AMAG Stock Holding History

FNY Managed Accounts’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-503
Closed -$34.7K – 627
2015
Q2 		$34.7K Buy
+503
New +$31.6K 0.04% 175

Other funds holding AMAG

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SIM
Stelliam Investment Management New York $404M AUM 5.1% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

FNY Managed Accounts's AMAG Position: Q3 2015 in Review

FNY Managed Accounts sold out of AMAG Pharmaceuticals (AMAG) in Q3 2015, closing a stake of 503 shares — an estimated $34.7K sold.

FNY Managed Accounts first reported a position in AMAG in Q2 2015 and held it in 1 quarter. The position peaked at $34.7K in Q2 2015. 210 funds tracked by Wall St. Rank hold AMAG as of Q3 2015.

  • FNY Managed Accounts reported no remaining AMAG Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • FNY Managed Accounts sold 503 AMAG Pharmaceuticals shares in Q3 2015, an estimated $34.7K.
  • FNY Managed Accounts first reported a position in AMAG Pharmaceuticals in Q2 2015 and held it in 1 quarter.
  • FNY Managed Accounts's AMAG Pharmaceuticals position peaked at $34.7K in Q2 2015.
  • 210 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2015.

Based on FNY Managed Accounts's 13F filing for Q3 2015, filed 27 Oct 2015.